常规超声联合增强CT预测甲状腺乳头状癌颈部淋巴结转移
本研究纳入建模组423例、验证组102例临床淋巴结阴性甲状腺乳头状癌患者,用常规超声联合颈部增强CT筛选中央区淋巴结转移的独立预测因素并建立简易风险评分模型;建模组AUC为0.790,验证组AUC为0.827,作者认为该联合检查有助于术前预测中央区淋巴结转移。
要点
- 年龄≤45岁、结节位于非上极、结节>12.5mm、TI-RADS评分≥9、标准化增强CT值≥0.75、包膜侵犯为中央区淋巴结转移独立危险因素。
- 中央区强化为中央区淋巴结转移的独立保护因素(OR=0.222)。
- 建模组模型AUC 0.790、敏感度70.4%、特异度73.9%;验证组AUC 0.827、敏感度88.9%、特异度63.2%。
核心结论
- 常规超声联合颈部增强CT可用于术前预测临床淋巴结阴性甲状腺乳头状癌患者的中央区淋巴结转移,所建简易风险评分模型可能有助于外科医生制定合适的手术方案和预后评估。
研究设计与样本
- 本研究为预测模型建模与验证研究,建模组纳入423例术前接受超声和增强CT评估的甲状腺乳头状癌患者,验证组纳入来自两家医院的102例患者;采用多因素logistic回归分析确定独立预测因素,并用受试者工作特征曲线分析评估诊断效能。
关键影像表现/征象
- 结节位于非上极(OR=2.385)、结节大小>12.5 mm(OR=2.130)、TI-RADS评分≥9(OR=2.857)、标准化增强CT值≥0.75(OR=3.132)、包膜侵犯(OR=3.478)与中央区淋巴结转移风险升高相关。
- 中央区强化与中央区淋巴结转移风险降低相关(OR=0.222)。
- 年龄≤45岁与中央区淋巴结转移风险升高相关(OR=3.950)。
诊断标准与关键数值
- 建模组模型预测中央区淋巴结转移的AUC为0.790(95%CI:0.747-0.834),敏感度70.4%,特异度73.9%。
- 验证组模型预测中央区淋巴结转移的AUC为0.827(95%CI:0.747-0.907),敏感度88.9%,特异度63.2%。
- 独立预测因素包括年龄≤45岁(OR=3.950)、结节位于非上极(OR=2.385)、结节大小>12.5 mm(OR=2.130)、TI-RADS评分≥9(OR=2.857)、标准化增强CT值≥0.75(OR=3.132)、中央区强化(OR=0.222)、包膜侵犯(OR=3.478)。
临床应用与阅片要点
- 作者认为常规超声联合颈部增强CT可用于术前预测中央区淋巴结转移,所建简易风险评分模型可能有助于外科医生制定合适的手术方案和预后评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to evaluate conventional ultrasound (US) combined with contrast-enhanced computed tomography (CT) of the neck to predict central lymph node metastasis (CLNM) in clinical lymph-negative patients with papillary thyroid carcinoma (PTC), establish a simple preoperative risk-scoring model, and validate its effectiveness in a two-center dataset.
METHODS: A total of 423 patients with PTC preoperatively evaluated by US and contrast-enhanced CT were included in the modeling group, and 102 patients from two hospitals were enrolled in the validation group. Independent predictive factors were determined using multivariate logistic regression analysis. Diagnostic performance was evaluated using receiver operating characteristic curve analysis.
RESULTS: The independent predictive factors for CLNM were age ≤45 years (odds ratio [OR] = 3.950), nodule presence in the non-upper pole (OR = 2.385), nodule size >12.5 mm (OR = 2.130), Thyroid Imaging Reporting and Data System score ≥9 (OR = 2.857), normalized enhancement CT value ≥0.75 (OR = 3.132), central enhancement (OR = 0.222), and capsular invasion (OR = 3.478). The area under the curve (AUC) of the model was 0.790 (95% confidence interval [CI]: 0.747-0.834), and the sensitivity and specificity were 70.4% and 73.9%, respectively. The AUC in the validation group was 0.827 (95% CI: 0.747-0.907), and the sensitivity and specificity were 88.9% and 63.2%, respectively.
CONCLUSIONS: We found conventional US combined with contrast-enhanced CT of the neck to be useful in predicting CLNM preoperatively and established a simple risk-scoring model that might help surgeons with appropriate surgical plans and prognostic evaluation.
引用
- Zhao, Yue, Wang, et al. Combined Conventional Ultrasound and Contrast-Enhanced Computed Tomography for Cervical Lymph Node Metastasis Prediction in Papillary Thyroid Carcinoma. J Ultrasound Med. 2022. PMID: 35634760. doi:10.1002/jum.16024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。